Get the Stockscreener App
13.71
0.81%
0.11
After Hours:
13.98
0.27
+1.97%
Oscar Health Inc stock is traded at $13.71, with a volume of 14.33M.
It is up +0.81% in the last 24 hours and down -22.37% over the past month.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
See More
Previous Close:
$13.60
Open:
$14.13
24h Volume:
14.33M
Relative Volume:
1.32
Market Cap:
$4.08B
Revenue:
$8.22B
Net Income/Loss:
$28.95M
P/E Ratio:
-228.50
EPS:
-0.06
Net Cash Flow:
$901.06M
1W Performance:
+9.59%
1M Performance:
-22.37%
6M Performance:
-8.48%
1Y Performance:
-0.36%
1-Day Range:
$13.39
$14.57
1-Week Range:
$11.85
$14.57
52-Week Range:
$11.20
$23.80
Oscar Health Inc Stock (OSCR) Company Profile
Name
Oscar Health Inc
Sector
Industry
Phone
(646) 403-3677
Address
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSCR
Oscar Health Inc
|
13.71 | 4.05B | 8.22B | 28.95M | 901.06M | -0.06 |
|
UNH
Unitedhealth Group Inc
|
284.37 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.93 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
287.61 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
336.04 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
178.83 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | UBS | Sell → Neutral |
| Jan-05-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Initiated | Stephens | Equal-Weight |
| Nov-26-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-15-25 | Downgrade | UBS | Neutral → Sell |
| Jul-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-02-25 | Initiated | Barclays | Underweight |
| Jun-24-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-24 | Initiated | Jefferies | Underperform |
| Nov-06-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-07-24 | Initiated | UBS | Neutral |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-22-24 | Initiated | Raymond James | Outperform |
| Nov-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-14-22 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-14-21 | Initiated | Goldman | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Mar-30-21 | Initiated | Wells Fargo | Overweight |
| Mar-29-21 | Initiated | BofA Securities | Buy |
| Mar-29-21 | Initiated | Cowen | Market Perform |
| Mar-29-21 | Initiated | Credit Suisse | Outperform |
| Mar-29-21 | Initiated | Goldman | Buy |
| Mar-29-21 | Initiated | Morgan Stanley | Overweight |
View All
Oscar Health Inc Stock (OSCR) Latest News
Raymond James upgrades Oscar Health stock rating to Outperform By Investing.com - Investing.com Nigeria
Raymond James upgrades Oscar Health on valuation and margin recovery outlook - Investing.com Canada
Raymond James Upgrade Boosts Oscar Health Stock After Q4 Earnings - Benzinga
Raymond James Upgrades Oscar Health to Outperform From Market Perform, Price Target is $18 - marketscreener.com
New Forecasts: Here's What Analysts Think The Future Holds For Oscar Health, Inc. (NYSE:OSCR) - simplywall.st
Raymond James upgrades Oscar Health stock rating to Outperform - Investing.com
Oscar Health Stock Gains: Key Insights - Intellectia AI
Oscar Health, Inc. (OSCR) Upgraded as Valuation Appears Balanced - Finviz
Oscar Health, Inc. (OSCR) upgraded as valuation appears balanced - MSN
Oscar Health projects 2026 revenue of up to $19B, membership reaches 3.4 million - Traders Union
Is Oscar Health (OSCR) one of the under-the-radar AI stocks to buy? - MSN
Is Oscar Health (OSCR) One of the Under-the-Radar AI Stocks to Buy? - Insider Monkey
Oscar Health Q4: Tricky 2025, Promising 2026Long-Term Bull Thesis Attractive (OSCR) - Seeking Alpha
Oscar Health, Inc. (NYSE:OSCR) Q4 2025 earnings call transcript - MSN
Oscar Health, Inc. (NYSE:OSCR) Q4 2025 Earnings Call Transcript - Insider Monkey
CVS, Oscar Health report diverging 2025 results - Insurance Business
Why Oscar Health (OSCR) Is Down 7.4% After Wider 2025 Losses But Confident 2026 Profit Outlook - Yahoo Finance UK
Oscar Health Q4 Earnings Call Highlights - MarketBeat
Oscar Health (OSCR) Sets Ambitious 2026 Revenue Outlook Amid Cha - GuruFocus
Oscar Health (OSCR) Projects Significant FY26 Earnings Growth - GuruFocus
Oscar Health Reports Optimistic Guidance Boosting Stock - Intellectia AI
Why Oscar Health Stock Ticked up on Tuesday - Yahoo Finance
Why Oscar Health Stock Ticked up on Tuesday - The Motley Fool
Oscar Health Charts Risky Path Toward 2026 Profitability - TipRanks
Schwab & Stifel fall, Paramount sweetens WBD bid, Oscar Health earnings - Yahoo Finance
House panel subpoenas 8 health insurers - The Hill
Oscar Health Inc (OSCR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Outlook ... By GuruFocus - Investing.com Canada
Oscar Health gains as outlook tops consensus (OSCR:NYSE) - Seeking Alpha
Oscar Health Bets On 2026 Profit Turnaround After Tough 2025Oscar Health (NYSE:OSCR) - Benzinga
Oscar Health (OSCR) Reports Strong Revenue Growth and Market Sha - GuruFocus
Oscar Health OSCR Q4 2025 Earnings Call Transcript - AOL.com
Oscar Health (OSCR) Stock Trades Up, Here Is Why - Finviz
Oscar Health Stock Surges on Upbeat 2026 Revenue GuidanceNews and Statistics - IndexBox
Oscar Health (NYSE:OSCR) Shares Gap UpHere's What Happened - MarketBeat
Oscar Health (OSCR) Reports Lower Q4 Revenue, Aims for Profitabi - GuruFocus
Oscar Health stock drops after Q4 results fall short despite upbeat 2026 guidance - MSN
Earnings call transcript: Oscar Health Q4 2025 misses EPS and revenue forecasts By Investing.com - Investing.com India
Earnings call transcript: Oscar Health Q4 2025 misses EPS and revenue forecasts - Investing.com
Oscar Health (OSCR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore
Oscar Health reports Q4 EPS ($1.24), consensus (92c) - TipRanks
Oscar Health (NYSE:OSCR) Posts Quarterly Earnings Results, Misses Expectations By $0.32 EPS - MarketBeat
Oscar Health (NYSE:OSCR) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings - Finviz
Why Is OSCR Stock Rising Today? - Stocktwits
Oscar Health Revenue Rises, Eyes Profitability This Year - The Wall Street Journal
Oscar Health Inc (NYSE:OSCR) Posts Wider Q4 Loss on Surging Medical Costs, Shares Drop - ChartMill
Oscar Health Reports Q4 Earnings Miss, Shares Drop Over 5% - Intellectia AI
Oscar Health (OSCR) Misses Q4 Earnings and Revenue Estimates - GuruFocus
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk - TechStock²
Oscar Health Q4 Loss Widens, Revenue Rises - marketscreener.com
Oscar Health Inc enters $475 million revolving credit facility on Feb 6SEC filing - marketscreener.com
Oscar Health Inc Stock (OSCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.67%
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):